Literature DB >> 17409133

Combined tumour necrosis factor-alpha and tumour necrosis factor receptor genotypes could predict rheumatoid arthritis patients' response to anti-TNF-alpha therapy and explain controversies of studies based on a single polymorphism.

A Chatzikyriakidou, I Georgiou, P V Voulgari, A I Venetsanopoulou, A A Drosos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17409133     DOI： 10.1093/rheumatology/kem041

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

Review 1.  [Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis: Where do we stand?].

Authors:  B Stuhlmüller; K Skriner; T Häupl
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

Review 2.  Application of omics in predicting anti-TNF efficacy in rheumatoid arthritis.

Authors:  Xi Xie; Fen Li; Shu Li; Jing Tian; Jin-Wei Chen; Jin-Feng Du; Ni Mao; Jian Chen
Journal:  Clin Rheumatol       Date:  2017-06-10       Impact factor: 2.980

Review 3.  Rheumatoid arthritis: strategies in the management of patients showing an inadequate response to TNFalpha antagonists.

Authors:  Joseph R Lutt; Atul Deodhar
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFalpha therapy in rheumatoid arthritis?

Authors:  Alessia Ongaro; Monica De Mattei; Agnese Pellati; Angelo Caruso; Stefano Ferretti; Federica Francesca Masieri; Maria Fotinidi; Ilaria Farina; Francesco Trotta; Melissa Padovan
Journal:  Rheumatol Int       Date:  2008-02-29       Impact factor: 2.631

5.  Association of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ischemic Stroke in a Greek Population.

Authors:  Sofia Markoula; Anthoula Chatzikyriakidou; Sotirios Giannopoulos; Kargiotis Odysseas; Sofia Markou; Konstantinos Vemmos; Ioannis Georgiou; Athanassios P Kyritsis
Journal:  Stroke Res Treat       Date:  2011-05-29

Review 6.  Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.

Authors:  Giovanni Pallio; Federica Mannino; Natasha Irrera; Ali H Eid; Francesco Squadrito; Alessandra Bitto
Journal:  Biomolecules       Date:  2020-08-19

Review 7.  Pharmacogenomics of Monoclonal Antibodies for the Treatment of Rheumatoid Arthritis.

Authors:  Sung Ho Lim; Khangyoo Kim; Chang-Ik Choi
Journal:  J Pers Med       Date:  2022-07-31

8.  Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.

Authors:  Darren D O'Rielly; Proton Rahman
Journal:  Pharmgenomics Pers Med       Date:  2010-03-30

9.  TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?

Authors:  A Scardapane; L Breda; M Lucantoni; F Chiarelli
Journal:  Int J Rheumatol       Date:  2012-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.